Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
August 8, 2017
Achaogen to Present at the Wedbush PacGrow Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
August 8, 2017
DURECT Corporation Announces Second Quarter 2017 Financial Results and Provides Corporate Update
CUPERTINO, Calif., Aug. 8, 2017 /PRNewswire/ -- DURECT Corporation (DRRX) today announced financial results for the three months ended June 30, 2017 and provided a corporate ...
August 8, 2017
TRACON Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
SAN DIEGO, Aug. 08, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
August 8, 2017
Prothena Reports Second Quarter 2017 Financial Results and Provides R&D Update
Prothena Corporation plc (PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein immunotherapies, today reported financial results for ...
August 8, 2017
Paratek Pharmaceuticals, Inc. to Present at Wedbush PacGrow Healthcare Conference
BOSTON, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK) today announced that its President, Chief Operating Officer and Chief Medical Officer, Evan Loh, ...
August 8, 2017
Aimmune Therapeutics’ Investigational Treatment for Peanut Allergy Featured in Science Translational Medicine Publication on Discovery of New TH2 Cell Subset Specific to Allergy
BRISBANE, Calif. -- (BUSINESS WIRE) -- Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that its investigational treatment for ...
August 8, 2017
Eiger BioPharmaceuticals to Present at 2017 Wedbush PacGrow Healthcare Conference on August 16th
PALO ALTO, Calif., Aug. 8, 2017 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today ...
August 8, 2017
Albireo to Present at Wedbush PacGrow Healthcare Conference
BOSTON, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
August 8, 2017
DURECT Corporation: ORADUR®-Methylphenidate ER Capsule Achieves Primary Endpoint in Phase 3 Study in ADHD in Taiwan
CUPERTINO, Calif., Aug. 8, 2017 /PRNewswire/-- DURECT Corporation (DRRX) today announced that Orient Pharma Co., Ltd., its licensee for certain Asian and South Pacific countries, ...
August 8, 2017
Onconova Therapeutics, Inc. to Provide Corporate Update and Second Quarter 2017 Financial Results
NEWTOWN, Pa., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to ...
August 8, 2017
La Jolla Pharmaceutical Company Announces Launch of Expanded Access Program for LJPC-501
SAN DIEGO -- (BUSINESS WIRE) -- La Jolla Pharmaceutical Company (LJPC) (the Company or La Jolla), today announced that the Company has initiated an expanded access ...
August 7, 2017
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2017 Financial Results
SAN DIEGO, Aug. 7, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today ...
August 7, 2017
CytoSorbents Reports Record Quarterly Total Revenue and Product Sales in the Second Quarter 2017
MONMOUTH JUNCTION, N.J., Aug. 7, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to prevent or treat ...
August 7, 2017
Reata Announces First Patient Enrolled in Phase 3 CARDINAL Trial of Bardoxolone Methyl in the Treatment of Chronic Kidney Disease Due to Alport Syndrome
IRVING, Texas, Aug. 07, 2017 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA) (“Reata” or the “Company”) today announced the enrollment of the first patient in the ...
August 7, 2017
BrainStorm Supports Commitment to ALS Patient Community with Appointment of a Vice President of Patient Advocacy and Government Affairs
HACKENSACK, N.J. and PETACH TIKVAH, Israel, Aug. 7, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative ...
August 7, 2017
Gemphire Announces Top-Line Data from ROYAL-1 Phase 2b Clinical Trial in Hypercholesterolemic Patients
LIVONIA, Mich., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP) today announced top-line data based upon the Company’s preliminary review of the limited ...
August 7, 2017
Bellerophon Reports Second Quarter 2017 Financial Results and Provides Business Update
WARREN, N.J., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH), a clinical-stage biotherapeutics company, today provided a business update and reported financial results for ...
August 7, 2017
Lipocine Announces Financial and Operational Results for the Second Quarter and Six Months Ended June 30, 2017
SALT LAKE CITY, Aug. 07, 2017 (GLOBE NEWSWIRE) -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced financial results for the three and six ...
August 7, 2017
CymaBay to Report Second Quarter 2017 Financial Results on Thursday, August 10
NEWARK, Calif., Aug. 07, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
August 7, 2017
Rexahn Pharmaceuticals Reports Second Quarter 2017 Financial and Operational Results
ROCKVILLE, Md., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment ...
Page 100 of 117